Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 2;12(3):617.
doi: 10.3390/diagnostics12030617.

Reply to Schramm, L. Comment on "Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364"

Affiliations

Reply to Schramm, L. Comment on "Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364"

Xiaoqing Li et al. Diagnostics (Basel). .

Abstract

We thank Professor Laura Schramm for her comment on the history and clarification of BDP1 nomenclature, her contribution to gene cloning [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Illustrating the timeline of nomenclature and difference between PTPN18 and BDP1 and their perspective involvement in cancer (refer to citations References [1,2,5,6,7,8,9,10,11,12,13,14,15,16] for details).

Similar articles

References

    1. Schramm L., Pendergrast P.S., Sun Y., Hernandez N. Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev. 2000;14:2650–2663. doi: 10.1101/gad.836400. - DOI - PMC - PubMed
    1. Schramm L., Hernandez N. Recruitment of RNA polymerase III to its target promoters. Genes Dev. 2002;16:2593–2620. doi: 10.1101/gad.1018902. - DOI - PubMed
    1. Schramm L. Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364. Diagnostics. 2022;12:608. doi: 10.3390/diagnostics12030608. - DOI - PMC - PubMed
    1. Li X., Sun L., Stucky A., Tu L., Cai J., Chen X., Wu Z., Jiang X., Li S.C. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics. 2021;11:2364. doi: 10.3390/diagnostics11122364. - DOI - PMC - PubMed
    1. Schoenen F., Wirth B. The zinc finger protein ZNF297B interacts with BDP1, a subunit of TFIIIB. Biol. Chem. 2006;387:277–284. doi: 10.1515/BC.2006.037. - DOI - PubMed